HYPERSENSITIVITY PNEUMONITIS
Clinical trials for HYPERSENSITIVITY PNEUMONITIS explained in plain language.
Never miss a new study
Get alerted when new HYPERSENSITIVITY PNEUMONITIS trials appear
Sign up with your email to follow new studies for HYPERSENSITIVITY PNEUMONITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled therapy aims to slow lung scarring in progressive fibrosis
Disease control Recruiting nowThis study tests an inhaled version of the drug pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis (PPF), a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their u…
Matched conditions: HYPERSENSITIVITY PNEUMONITIS
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
Leg muscle weakness may be the hidden cause of breathlessness in lung scarring patients
Knowledge-focused Recruiting nowThis study looks at whether leg muscle issues contribute to shortness of breath and exercise problems in people with interstitial lung disease (ILD). Researchers will compare leg muscle structure and function in 40 ILD patients, and test if muscle fatigue limits exercise. They wi…
Matched conditions: HYPERSENSITIVITY PNEUMONITIS
Phase: NA • Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated May 26, 2026 05:43 UTC
-
New biobank aims to unlock secrets of rare lung diseases
Knowledge-focused Recruiting nowThis study is creating a registry and biobank for people with interstitial lung diseases (ILD), including sarcoidosis and pulmonary fibrosis. Researchers will collect medical data and biological samples from up to 1,000 participants to support future studies. The goal is to bette…
Matched conditions: HYPERSENSITIVITY PNEUMONITIS
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC